ACUTAAS
NSEAcutaas Chemicals Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹3,400.80
58.00 (1.68%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹27.84K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
79.5
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹1,117.6+204.3%
52W High₹3,740-9.1%
Current Price
₹3,400.80
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹2,720.64
Upper Circuit₹4,080.96
Reference Price
₹3,400.80
Investment Checklist
Ascending Channel on 1D — target ₹3502.82
Bull Flag on 1D — target ₹3669.4
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Composite score 48.81 (BUY) with 51.4% confidence
Volume divergence: Bullish (price down, volume up)
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
51%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
3372.12
EMA50
3110.97
EMA200
2320.76
Price Action
UPTREND
BULLISH
Higher Highs6
Higher Lows6
Lower Highs3
Lower Lows3
Support & Resistance Levels
Resistance (Above)
₹3444.30
Support (Below)
₹2960.20
₹2634.80
₹2580.00
₹2297.30
₹2255.60
Volume Analysis
TrendINCREASING
Change+86.50%
Unusual VolumeNo
Divergence Detected
Bullish (price down, volume up)
Stop Loss Levels
Fixed Risk
1% Risk₹3366.79
3% Risk₹3298.78
5% Risk₹3230.76
7% Risk (Custom)
₹3162.74Technical Levels
1x ATR (Volatility)₹3254.94
2x ATR (Swing)₹3109.08
3x ATR (Trend)₹2963.22
Immediate Support₹2960.20
Moving Averages
EMA 20 (Medium-term)₹3372.12
EMA 50 (Trend)₹3110.97
EMA 200 (Long-term)₹2320.76
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹275 Cr | ₹301.6 Cr | ₹207.2 Cr | ₹393.2 Cr |
| Net Profit | ₹45 Cr | ₹62.5 Cr | ₹44.3 Cr | ₹108 Cr |
| EPS | ₹5.68 | — | ₹5.41 | ₹13.19 |
| Operating Profit | ₹70.3 Cr | ₹90.7 Cr | ₹66.8 Cr | ₹155.4 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Acutaas Chemicals Limited | ₹3,400.80 | -1.68% | 79.5 | ₹27.84K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 18 Sept 2025 | Dividend - Rs 1.50 Per Share | DIVIDEND |
| 25 Apr 2025 | Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 5/- Per Share | STOCK_SPLIT |
| 13 Sept 2024 | Annual General Meeting | AGM |
| 13 Sept 2024 | Dividend - Rs 3 Per Share | DIVIDEND |
| 18 Sept 2023 | Dividend - Rs 3 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for ACUTAAS
View AllNEWS
positive
Business Standard - Markets 2d ago
Volumes soar at Acutaas Chemicals Ltd counter
Acutaas Chemicals Ltd clocked volume of 4 lakh shares by 10:46 IST on BSE, a 12.77 times surge over two-week average daily volume of 31312 shares
ACUTAASBSEJGCHEMChemicalsFinancial Services
positive
Business Standard - Markets 3d ago
Pharma stocks: Lupin, Torrent hit new peaks; Sun nears summit; here's why
Pharma stock rally: Orchid Pharma, Hikal, Unichem Labs, IOL Chemicals, SPARC, RPG Life Sciences and Acutaas Chemicals surged up to 13% in Wednesday's trade.
ABGSECABSL10BANKABSLAMCABSLBANETFABSLLIQUIDABSLNN50ETABSLPSEACUTAASALIVUSBSLGOLDETFBSLNIFTYBSLSENETFGGSEC10ABSLHEALTHYHIKALIOLCPJFLLIFEJFL-REJGCHEMLUPINMOMENTUMNIFTYQLITYORCHPHARMARPGLIFESAILIFESILVERSOLARASPARCSUVENTECHChemicalsFinancial Services
positive
ET Markets - Stocks 9d ago
10 smallcap stocks soar up to 212% this year, 3 turn multibaggers. Do you own any?
India's smallcap stocks have outperformed the Nifty 50 in 2026, with HFCL, Aditya Infotech and Acutaas Chemicals leading the top 10 performers, delivering exceptional year-to-date returns.
3IINFOLTDABSL10BANKABSLBANETFABSLNN50ETABSLPSEACUTAASAXISBPSETFBSLNIFTYCHEMICALCPPLUSGROWWCHEMGROWWSC250GSEC10ABSLHDFCSML250HEALTHYHFCLJGCHEMMOMENTUMMOSMALL250NIFTYQLITYSDL26BEESSMALL250SMALLADDSMALLCAPSML100CASETECHTOP10ADDTOP15IETFTOP20Capital GoodsChemicals